Synlogic lands $40 mln in Series B financing
Synlogic, a biopharmaceutical company based in Cambridge, Massachusetts, raised $40 million in a Series B funding round led by OrbiMed HealthCare Fund Management. Deerfield Management Company and founding investors Atlas Venture and New Enterprise Associates also participated in the funding. Synlogic has raised $70 million across its Series A and Series B rounds.
17 February 2016•3 mins read
